Quadrant Capital Group’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $668K | Buy |
12,158
+1,148
| +10% | +$63.1K | 0.02% | 695 |
|
|
2025
Q1 | $778K | Buy |
11,010
+9,234
| +520% | +$653K | 0.03% | 490 |
|
|
2024
Q4 | $117K | Buy |
1,776
+658
| +59% | +$43.3K | 0.01% | 976 |
|
|
2024
Q3 | $78.6K | Buy |
1,118
+687
| +159% | +$48.3K | 0.01% | 1217 |
|
|
2024
Q2 | $35.5K | Buy |
431
+266
| +161% | +$21.9K | ﹤0.01% | 1579 |
|
|
2024
Q1 | $14.4K | Buy |
165
+14
| +9% | +$1.22K | ﹤0.01% | 1979 |
|
|
2023
Q4 | $14.6K | Buy |
151
+19
| +14% | +$1.83K | ﹤0.01% | 1929 |
|
|
2023
Q3 | $11.7K | Sell |
132
-327
| -71% | -$28.9K | ﹤0.01% | 1933 |
|
|
2023
Q2 | $39.8K | Sell |
459
-62
| -12% | -$5.37K | ﹤0.01% | 1374 |
|
|
2023
Q1 | $50.7K | Buy |
521
+290
| +126% | +$28.2K | 0.01% | 1237 |
|
|
2022
Q4 | $23.9K | Sell |
231
-17
| -7% | -$1.76K | ﹤0.01% | 1578 |
|
|
2022
Q3 | $21K | Sell |
248
-107
| -30% | -$9.06K | ﹤0.01% | 1501 |
|
|
2022
Q2 | $29K | Buy |
355
+232
| +189% | +$19K | ﹤0.01% | 1113 |
|
|
2022
Q1 | $9K | Sell |
123
-120
| -49% | -$8.78K | ﹤0.01% | 1680 |
|
|
2021
Q4 | $21K | Buy |
243
+8
| +3% | +$691 | ﹤0.01% | 1279 |
|
|
2021
Q3 | $18K | Sell |
235
-10
| -4% | -$766 | ﹤0.01% | 1281 |
|
|
2021
Q2 | $20K | Sell |
245
-104
| -30% | -$8.49K | ﹤0.01% | 1194 |
|
|
2021
Q1 | $26K | Buy |
349
+115
| +49% | +$8.57K | ﹤0.01% | 1067 |
|
|
2020
Q4 | $21K | Sell |
234
-13
| -5% | -$1.17K | ﹤0.01% | 1074 |
|
|
2020
Q3 | $19K | Sell |
247
-521
| -68% | -$40.1K | ﹤0.01% | 967 |
|
|
2020
Q2 | $95K | Sell |
768
-854
| -53% | -$106K | 0.02% | 471 |
|
|
2020
Q1 | $137K | Buy |
1,622
+1,111
| +217% | +$93.8K | 0.02% | 474 |
|
|
2019
Q4 | $41K | Sell |
511
-432
| -46% | -$34.7K | ﹤0.01% | 1431 |
|
|
2019
Q3 | $62K | Sell |
943
-940
| -50% | -$61.8K | 0.01% | 1134 |
|
|
2019
Q2 | $156K | Buy |
1,883
+643
| +52% | +$53.3K | 0.02% | 671 |
|
|
2019
Q1 | $105K | Buy |
1,240
+880
| +244% | +$74.5K | 0.02% | 780 |
|
|
2018
Q4 | $26K | Sell |
360
-82
| -19% | -$5.92K | 0.01% | 1097 |
|
|
2018
Q3 | $38K | Hold |
442
| – | – | 0.01% | 742 |
|
|
2018
Q2 | $36K | Buy |
442
+113
| +34% | +$9.2K | 0.01% | 761 |
|
|
2018
Q1 | $21K | Sell |
329
-30
| -8% | -$1.92K | 0.01% | 933 |
|
|
2017
Q4 | $27K | Sell |
359
-95
| -21% | -$7.15K | 0.01% | 818 |
|
|
2017
Q3 | $36K | Buy |
454
+52
| +13% | +$4.12K | 0.01% | 701 |
|
|
2017
Q2 | $31K | Buy |
402
+81
| +25% | +$6.25K | 0.01% | 708 |
|
|
2017
Q1 | $23K | Buy |
321
+48
| +18% | +$3.44K | 0.01% | 784 |
|
|
2016
Q4 | $17K | Sell |
273
-59
| -18% | -$3.67K | 0.01% | 811 |
|
|
2016
Q3 | $26K | Hold |
332
| – | – | 0.02% | 655 |
|
|
2016
Q2 | $22K | Buy |
332
+196
| +144% | +$13K | 0.02% | 662 |
|
|
2016
Q1 | $9K | Buy |
136
+31
| +30% | +$2.05K | 0.01% | 991 |
|
|
2015
Q4 | $8K | Buy |
105
+27
| +35% | +$2.06K | 0.01% | 866 |
|
|
2015
Q3 | $8K | Buy |
+78
| New | +$8K | 0.01% | 719 |
|